ZYDUSLIFE.BO

Zydus Lifesciences Limited

HealthcareDrug Manufacturers - Specialty & GenericININRPeers →Country macro →

$1,070.90

-0.77%Jun 19, 2026

AI Brief

Market cap

$1.08T

52w range

—

P / E

—

EPS · FY 2026

$50.09

Volume

—

Revenue · FY 2026

$271.48B

+16.81% YoY

Overview Fundamentals Valuation Market Ownership & flow Narrative & AI

Explain this page

Arphra AIPlain-English read on Zydus Lifesciences Limited’s valuation

AI Issuer Brief

Arphra AI

Loading cached brief…

Price

DB · prices_daily

1M 6M 1Y 5Y

Last

$1070.90

Change

+12.38%

Period high

$1106.10

Period low

$860.55

Period start

$952.952025-06-23

Through 2026-06-19

Fair value

Football field →

Weighted blend

$1,119.59

— vs spot

Recommendation

n/a

3 of 3 methods

Method spread

0bull0bear

±5% threshold

Candlestick · 1Y

Open in chart workstation →

ZYDUSLIFE.BO

1,071+12.38%

H 1,119L 835.85MA50 999.50MA200 954.75Avg vol 43K

Insider · 30d

History →

Bought

0 txns

Sold

0 txns

Net flow

+$0

Recent quarters

All financials →

Period	Revenue	Net income	EPS
Q1 Jun 2025	$65.74B	$14.67B	$14.58

Sector & industry today

Live

Sectors

Technology
+2.51%
Communication Services
+1.85%
Utilities
+1.35%
Consumer Cyclical
+0.30%
Industrials
+0.22%
Consumer Defensive
-0.30%
Real Estate
-0.34%
Energy
-0.45%
Basic Materials
-0.66%
Financial Services
-0.67%
Healthcare
-1.51%

Top industries (issuer's industry highlighted)

Drug Manufacturers - Specialty & Generic
-0.91%
Electronic Gaming & Multimedia
+7.50%
Business Equipment & Supplies
+5.82%
Semiconductors
+5.24%
Advertising Agencies
-5.20%
Medical - Equipment & Services
+5.08%
Oil & Gas Energy
-4.86%
Consulting Services
-4.82%
Grocery Stores
-4.35%
Computer Hardware
-3.67%
Coal
-3.56%
Other Precious Metals
-3.55%

Analyst view

Consensus target

—

No price-target data returned for this ticker.

Recent actions

0 ↑0 ↓0 hold

No recent grade actions.

News

DB · news_items

No recent news for ZYDUSLIFE.BO.

Peers

No peer list available for ZYDUSLIFE.BO.

Total assets

$524.07B

Total debt

$124.96B

Cash & equiv

$14.17B

Operating CF

$21.91B

Free cash flow

-$12.03B

Buybacks

Recent insiders

All →

Insider	Action	Shares	Value	Date
No open-market insider activity in the recent window.

Income statement · annual

Open Financials →

Period	Revenue	Op income	Net income	EPS	Net margin
FY 2026	$271.48B	$57.87B	$50.4B	$50.09	+18.56%
FY 2025	$232.42B	$96.04B	$45.26B	$44.97	+19.47%
FY 2024	$195.47B	$75.96B	$38.6B	$37.91	+19.74%